Market Size of Needle-Free Drug Delivery Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 7.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Needle-Free Drug Delivery Devices Market Analysis
The needle-free drug delivery devices market is expected to grow from USD 18.8 billion to USD 27.5 billion by 2028, register a CAGR of 7.9% over the forecast period.
- COVID-19 impacted the studied market, as the demand for needle-free devices increased during the pandemic for vaccination. However, the volume of these devices was not significant due to less adoption of needle-free devices over syringes. Some pharmaceutical companies and governments worked toward offering efficient medical treatment to COVID-19 patients, and needle-free drug delivery devices played a vital role in that context as these devices were used in administering drugs and vaccines.
- For instance, in December 2022, the government of India approved Bharat Biotech's intranasal vaccine for COVID-19. Also, various institutes performed research studies for the development of needle-free vaccine delivery systems. Therefore, the market reported a slight growth during the pandemic. Moreover, with the ongoing vaccinations, approval of needle-free vaccines, and the emergence of new covid strains, the demand for needle-free drug delivery devices is further expected to increase during the forecast period.
- The rising prevalence of chronic diseases requiring long hospital stays is expected to propel the market growth. As needle-free devices reduce the risk of safe needle disposal and avoid accidental needle stick injuries, propelling the market growth. For instance, according to the American Cancer Society Cancer Statistics 2023, 1.9 million new cancer cases are predicted to be diagnosed in the United States in 2023. The high burden of cancer creates an opportunity for market players the development of innovative needle-free drug delivery devices for cancer, which is expected to propel market growth.
- In addition, various research studies conducted for the development of technologically advanced needle-free drug delivery devices are also contributing to the market's growth. For instance, as per a research study published in Pharmaceutics Journal in November 2021, a compressed air-driven needle-free jet injection system with a hydro-pneumatic mechanism was designed and developed for controlled release and repeated biopharmaceutical delivery. Thus, the rising research activities to develop advanced needle-free drug delivery devices are expected to propel market growth.
- Furthermore, various companies are adopting strategic initiatives such as product innovation, launches, partnerships, and expansions for the development and expansion of needle-free drug delivery devices, propelling the market growth. For instance, in May 2022, Gerresheimer AG expanded its portfolio of technologies for drug delivery by investing in US-based Portal Instruments, a developer of a next-generation needle-free drug delivery technology. The partnership is aimed at improving the patient's experience, especially for those with chronic diseases, by transforming the administration of injectable biologics and biosimilars. Such expansions of the portfolio with innovative technologies and partnership among market players is expected to propel market growth.
- Therefore, owing to the aforementioned factors, such as the high burden of chronic diseases and rising research and development and product launches, the studied market is anticipated to witness growth over the analysis period. However, the stringent regulatory framework and limitations associated with using micro-needle patches are the few factors restraining the growth of the global needle-free drug delivery devices market.
Needle-Free Drug Delivery Devices Industry Segmentation
As per the scope of this report, needle-free drug delivery systems are novel ways to introduce various medicines to patients without piercing the skin with a needle. This method has drastically increased the adoption of important drugs through self-injections.
The needle-free drug delivery devices market is segmented by device type (inhalers, jet injectors, novel needles, transdermal patches, and other devices), application (insulin delivery, vaccination, pain management, and other applications), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally.
The report offers the value (in USD) for the above segments.
| By Device Type | |
| Inhalers | |
| Jet Injectors | |
| Novel Needles | |
| Transdermal Patches | |
| Other Devices |
| By Application | |
| Insulin Delivery | |
| Vaccination | |
| Pain Management | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Needle-Free Drug Delivery Devices Market Size Summary
The needle-free drug delivery devices market is poised for significant growth, driven by the increasing demand for innovative and safer drug administration methods. The market's expansion is fueled by the rising prevalence of chronic diseases, such as cancer and diabetes, which necessitate long-term treatment and frequent drug delivery. Needle-free devices offer advantages like reducing the risk of needle stick injuries and eliminating the need for safe needle disposal, making them an attractive alternative to traditional syringes. The COVID-19 pandemic further accelerated interest in these devices, as they were utilized for efficient vaccine and drug administration. Ongoing research and development efforts, along with strategic partnerships and product innovations, are expected to propel the market forward, despite challenges posed by regulatory frameworks and limitations of certain technologies.
The insulin delivery segment, in particular, is anticipated to experience robust growth due to the increasing incidence of diabetes and the adoption of advanced needle-free products. The advantages of needle-free insulin delivery systems, such as improved patient satisfaction and safety, are driving their demand. North America is expected to hold a significant market share, supported by the high burden of chronic diseases and active research and development initiatives by key players. The region's market growth is further bolstered by regulatory approvals and technological advancements in needle-free devices. The competitive landscape is characterized by the presence of innovative companies like Halozyme, Inc., 3M, and PharmaJet, which are leading the charge in developing novel needle-free drug delivery solutions.
Needle-Free Drug Delivery Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
-
1.2.2 High Burden of Needle-stick Injuries
-
1.2.3 Technological Innovation & Inclination of Population towards Self-administration of Drugs
-
-
1.3 Market Restraints
-
1.3.1 Stringent Regulatory Framework
-
1.3.2 Limitations Associated with the Use of Micro-Needle Patches
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Device Type
-
2.1.1 Inhalers
-
2.1.2 Jet Injectors
-
2.1.3 Novel Needles
-
2.1.4 Transdermal Patches
-
2.1.5 Other Devices
-
-
2.2 By Application
-
2.2.1 Insulin Delivery
-
2.2.2 Vaccination
-
2.2.3 Pain Management
-
2.2.4 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Needle-Free Drug Delivery Devices Market Size FAQs
What is the current Needle-Free Drug Delivery Devices Market size?
The Needle-Free Drug Delivery Devices Market is projected to register a CAGR of 7.90% during the forecast period (2024-2029)
Who are the key players in Needle-Free Drug Delivery Devices Market?
PharmaJet, 3M, MannKind Corporation, Mika Medical Co. and Halozyme, Inc. (Antares Pharma) are the major companies operating in the Needle-Free Drug Delivery Devices Market.
